What Happened?
Florham Park, NJ-based PDS-Biotechnology Appointed Matthew Hill as Chief Financial Officer
About the Company
PDS Biotech is a clinical-stage biopharmaceutical company focused on the development and commercialization of therapies based on the Versamune® platform, a T-cell activating technology, designed to harness the power of the body`s immune system in the fight against cancer and infectious disease.
About the Person
Matthew Hill is Chief Financial Officer at PDS Biotechnology. Previously, Matthew held various senior HR leadership roles in the industry.
Info Source
News
Short Profile